Intco Medical Technology Statistics

Total Valuation

Intco Medical Technology has a market cap or net worth of CNY 15.61 billion. The enterprise value is 10.77 billion.

Market Cap	15.61B
Enterprise Value	10.77B

Important Dates

The next estimated earnings date is Thursday, April 24, 2025.

Earnings Date	Apr 24, 2025
Ex-Dividend Date	Oct 31, 2024

Share Statistics

Intco Medical Technology has 641.68 million shares outstanding. The number of shares has decreased by -1.45% in one year.

Current Share Class	n/a
Shares Outstanding	641.68M
Shares Change (YoY)	-1.45%
Shares Change (QoQ)	+2.62%
Owned by Insiders (%)	36.32%
Owned by Institutions (%)	23.46%
Float	403.09M

Valuation Ratios

The trailing PE ratio is 21.54 and the forward PE ratio is 12.94.

PE Ratio	21.54
Forward PE	12.94
PS Ratio	1.78
PB Ratio	0.96
P/TBV Ratio	0.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.70, with an EV/FCF ratio of -9.70.

EV / Earnings	14.56
EV / Sales	1.20
EV / EBITDA	7.70
EV / EBIT	17.53
EV / FCF	-9.70

Financial Position

The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.78.

Current Ratio	1.48
Quick Ratio	1.36
Debt / Equity	0.78
Debt / EBITDA	9.48
Debt / FCF	-11.95
Interest Coverage	2.43

Financial Efficiency

Return on equity (ROE) is 4.52% and return on invested capital (ROIC) is 1.48%.

Return on Equity (ROE)	4.52%
Return on Assets (ROA)	1.30%
Return on Capital (ROIC)	1.48%
Revenue Per Employee	820,475
Profits Per Employee	67,612
Employee Count	10,939
Asset Turnover	0.30
Inventory Turnover	6.50

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.22% in the last 52 weeks. The beta is 0.76, so Intco Medical Technology's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	+8.22%
50-Day Moving Average	26.89
200-Day Moving Average	25.67
Relative Strength Index (RSI)	34.66
Average Volume (20 Days)	12,129,738

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Intco Medical Technology had revenue of CNY 8.98 billion and earned 739.61 million in profits. Earnings per share was 1.13.

Revenue	8.98B
Gross Profit	1.88B
Operating Income	614.19M
Pretax Income	781.28M
Net Income	739.61M
EBITDA	1.40B
EBIT	614.19M
Earnings Per Share (EPS)	1.13

Full Income Statement

Balance Sheet

The company has 18.38 billion in cash and 13.27 billion in debt, giving a net cash position of 5.11 billion or 7.97 per share.

Cash & Cash Equivalents	18.38B
Total Debt	13.27B
Net Cash	5.11B
Net Cash Per Share	7.97
Equity (Book Value)	16.95B
Book Value Per Share	25.27
Working Capital	6.97B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 775.52 million and capital expenditures -1.89 billion, giving a free cash flow of -1.11 billion.

Operating Cash Flow	775.52M
Capital Expenditures	-1.89B
Free Cash Flow	-1.11B
FCF Per Share	-1.73

Full Cash Flow Statement

Margins

Gross margin is 20.96%, with operating and profit margins of 6.84% and 8.24%.

Gross Margin	20.96%
Operating Margin	6.84%
Pretax Margin	8.70%
Profit Margin	8.24%
EBITDA Margin	15.54%
EBIT Margin	6.84%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.40%.

Dividend Per Share	0.10
Dividend Yield	0.40%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	37.78%
Buyback Yield	1.45%
Shareholder Yield	1.84%
Earnings Yield	4.64%
FCF Yield	-7.12%

Dividend Details

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 1.2.

Last Split Date	Jun 13, 2022
Split Type	Forward
Split Ratio	1.2

Scores

Intco Medical Technology has an Altman Z-Score of 1.75. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.75
Piotroski F-Score	n/a